Robert J. Bitterman
2022
In 2022, Robert J. Bitterman earned a total compensation of $109.4K as President and Chief Executive Officer at RXi Pharmaceuticals, a 40% increase compared to previous year.
Compensation breakdown
| Salary | $77,885 |
|---|---|
| Stock Awards | $31,464 |
| Other | $31 |
| Total | $109,380 |
Bitterman received $77.9K in salary, accounting for 71% of the total pay in 2022.
Bitterman also received $31.5K in stock awards and $31 in other compensation.
Rankings
In 2022, Robert J. Bitterman's compensation ranked 5,590th out of 5,760 executives tracked by ExecPay. In other words, Bitterman earned more than 3.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,590 out of 5,760 | 3rd |
Division Manufacturing | 3,052 out of 3,136 | 3rd |
Major group Chemicals And Allied Products | 1,391 out of 1,422 | 2nd |
Industry group Drugs | 1,298 out of 1,323 | 2nd |
Industry Pharmaceutical Preparations | 947 out of 969 | 2nd |
Source: SEC filing on June 9, 2023.
Bitterman's colleagues
We found two more compensation records of executives who worked with Robert J. Bitterman at RXi Pharmaceuticals in 2022.